Viewing nowUntelmi Tablet 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
U&Life Sciences Co., Ltd.

MFDS item code 202001377 · Approved 2020.02.27 · Insurance code 058800760
Treatment of essential hypertension; prevention of cardiovascular events (including myocardial infarction and stroke)
This medication is used for the treatment of essential hypertension, effectively regulating blood pressure and lowering the risk of cardiovascular diseases. It is particularly suitable for patients over 55 years who are at high risk and cannot be treated with ACE inhibitors, including those with a history of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and stroke, or patients who have developed end-organ damage due to diabetes. This medication helps reduce the risk of death from myocardial infarction, stroke, and cardiovascular diseases. Therefore, it can be expected to control blood pressure and prevent cardiovascular complications simultaneously. It is used to reduce the risk of cardiovascular diseases tailored to the patient's health status.
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. Concomitant administration of this medicine with thiazide diuretics such as hydrochlorothiazide produces an additional blood pressure-lowering effect. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to patients with hypersensitivity to this drug or to women who are pregnant or breastfeeding, those with severe liver impairment, patients with hereditary angioedema, and those with certain kidney diseases. Elderly patients, those with hyperkalemia, patients with mild to moderate liver impairment, and patients with heart valve disease should use this medication with special caution. While taking this medication, blood pressure, kidney function, and serum electrolyte levels should be monitored regularly, and if unusual symptoms appear, medical advice should be sought immediately. Caution is needed when taking this medication with other antihypertensives, as it may enhance the blood pressure-lowering effect. Particularly, taking this medication along with ACE inhibitors, aliskiren, and others increases the risk of hypotension, hyperkalemia, and renal function deterioration. This medication may cause dizziness or fainting when driving or operating dangerous machinery, so caution is necessary. In the case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, and immediate medical treatment is required. It is not recommended for children and adolescents under 18 as its safety and efficacy have not been established. Store this medication out of the reach of children, and use it only after opening the packaged aluminum foil.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent air or moisture from entering. It is best to store it at room temperature between 1 degree and 30 degrees. This way, the effectiveness of the medication can be well maintained.
White or almost white oval tablet
30 tablets/box[((10 tablets/AluAlu)*3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
U&Life Sciences Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.